| Literature DB >> 29673341 |
Ricky Watari1,2, Sean T Osis1,3, Angkoon Phinyomark4, Reed Ferber5,6,7,8.
Abstract
BACKGROUND: Previous studies have suggested that distinct and homogenous sub-groups of gait patterns exist among runners with patellofemoral pain (PFP), based on gait analysis. However, acquisition of 3D kinematic data using optical systems is time consuming and prone to marker placement errors. In contrast, axial segment acceleration data can represent an overall running pattern, being easy to acquire and not influenced by marker placement error. Therefore, the purpose of this study was to determine if pelvic acceleration patterns during running could be used to classify PFP patients into homogeneous sub-groups. A secondary purpose was to analyze lower limb kinematic data to investigate the practical implications of clustering these subjects based on 3D pelvic acceleration data.Entities:
Keywords: Biomechanics; Cluster analysis; Gait analysis; Patellofemoral pain; Pelvic acceleration; Principal component analysis; Running kinematics
Mesh:
Year: 2018 PMID: 29673341 PMCID: PMC5907713 DOI: 10.1186/s12891-018-2045-3
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Inclusion and exclusion criteriaa
| Inclusion criteria | |
| 1. Insidious onset of symptoms unrelated to trauma and persistent for at least 4 wk | |
| 2. Pain in the anterior knee associated with at least 3 of the following: | |
| a. During or after activity (running and other physical activity modalities) | |
| b. Prolonged sitting | |
| c. Stair ascent or descent | |
| d. Squatting | |
| 3. Pain with palpation of the patellar facets or pain during step down from a 20-cm box or during a double-legged squat | |
| Exclusion criteria | |
| 1. Meniscal or other intra-articular injury | |
| 2. Cruciate or collateral ligament laxity or tenderness | |
| 3. Positive patellar-apprehension sign | |
| 4. Evidence of effusion | |
| 5. History of recurrent patellar subluxation or dislocation | |
| 6. History of surgery to the knee joint | |
| 7. Nonsteroidal anti-inflammatory drug or corticosteroid use within 24 hours before testing | |
| 8. History of head injury or vestibular disorder within the last 6 months | |
| 9. Pregnancy | |
aadapted from Ferber et al. (2015) [3]
Fig. 1Dendrogram of the hierarchical cluster analysis. Clustering of PFP patients produced by the hierarchical cluster analysis. a Male subjects; (b) Female subjects
Number of PFP participants and subject specifications (Mean and (SD)) for the determined clusters
| Males ( | Females_C1 ( | Females_C2 ( | |
|---|---|---|---|
| Age [years]a | 35.1 (1.5) | 30.9 (2.0) | 36.4 (1.6) |
| Height [m]b | 1.79 (0.01)* | 1.66 (0.01) | 1.66 (0.01) |
| Mass [kg]b | 77.2 (1.3)* | 59.1 (1.7) | 63.4 (1.4) |
| Running speed [m/s]b | 2.66 (0.03) | 2.60 (0.04) | 2.57 (0.03) |
| Years running [years]b | 8.6 (8.0) | 7.0 (7.1) | 9.0 (7.7) |
| Involvement [uni/bilateral]c | 20 / 24 | 13 / 13 | 14 / 26 |
| Injury site [single/multiple]c | 33 / 11 | 19 / 7 | 32 / 8 |
aOne-way ANOVA; b Kruskal-Wallis test; c chi-squared test; * significantly different from other 2 groups
Mean and standard deviation of PC scores, vertical displacement and peak joint angles
| Males ( | Female C1 ( | Female C2 ( | |
|---|---|---|---|
| PC 1 [a.u.] a | 2.84 (0.8) | 4.6 (1.1) |
|
| PC 5 [a.u.] a | 1.4 (0.6) |
| 1.4 (0.7) |
| Vertical displacement [mm] a | 104.7 (2.1) |
| 98.9 (2.2) |
| Ankle eversion [o] b |
| 4.1 (0.8) | 4.2 (0.7) |
| Knee flexion [o] b | 44.6 (0.9) | 43.2 (1.2) | 44.2 (0.9) |
| Knee abduction [o] b |
| 11.9 (0.9) | 12.4 (0.7) |
| Knee external rotation [o] a | 10.0 (1.4) | 11.1 (1.8) | 7.6 (1.4) |
| Hip adduction [o] a |
| 10.9 (0.9) | 11.6 (0.7) |
| Hip internal rotation [o] a |
|
| 15.8 (1.1) |
aOne-way ANOVA; b Kruskal-Wallis test; * significantly different from the other 2 groups; # significant difference between the indicated groups
Bold number indicates a large effect size (d > 0.8)
Fig. 2Time-normalized pelvic accelerations. a Vertical acceleration, (b) Anteroposterior acceleration, and (c) Mediolateral acceleration for males and female sub-groups C1 and C2 during stance phase (1%–80%) and flight phase (81%–100%; gray area) of running. Regions represented by the significant principal components are indicated in the graphs